🧠 Parkinson's Digest Give Feedback
  • All
  • Research
  • Trials
  • News
Bracing for Walking in Parkinson's Disease
Trial N/A Completed March 22, 2022
Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment
Trial Phase 1 Completed March 21, 2022
Visual Spatial Exploration and Art Therapy Intervention in Patients Diagnosed With Parkinson's Disease
Trial N/A Completed March 20, 2022
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Trial Phase 1 Completed March 20, 2022
Effects of Routine Physical Therapy With and Without Proprioceptive Neuromuscular Facilitation on Balance, Gait and Function in Patients With Parkinson's Disease
Trial N/A Completed March 17, 2022
Assessment of Transcranial Electrical Stimulation and Auditory Stimulation During Walking in Parkinson Patients
Trial N/A Unknown March 17, 2022
Finding the Right Words in Neurogenic Communication Disorders
Trial N/A Completed March 15, 2022
Use and Misuse of Domperidone in Parkinson's Disease in France - Observational
Trial N/A Terminated March 14, 2022
Lifestyle and Non-motor Symptom Management in Parkinson's Disease
Trial N/A Terminated March 10, 2022
Cannabis Oil for Pain in Parkinson's Disease
Trial Phase 2 Unknown March 9, 2022
Role of Sleep on Motor Learning in Parkinson's Disease and Healthy Older Adults
Trial N/A Unknown March 8, 2022
Assessment of Empathetic Process by Scanpath Study of an Artwork
Trial N/A Completed March 8, 2022
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
Trial Phase 2 Completed March 1, 2022
A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants
Trial Phase 3 Completed March 1, 2022
A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants
Trial Phase 3 Completed March 1, 2022
Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
Trial Phase 2 Withdrawn March 1, 2022
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
Trial Phase 3 Completed March 1, 2022
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's Disease
Trial Phase 2 Terminated Feb. 27, 2022
Cognitive-driven ADL Impairment as a Predictor for PDD
Trial N/A Completed Feb. 23, 2022
Investigation of Gait, Foot Pressure Distribution and Balance in Parkinson's Patients With Motor Freezing
Trial N/A Completed Feb. 21, 2022
Previous Next

Parkinson's Digest provides access to the latest Parkinson's disease news, research, and clinical trials.

Feedback | Privacy Policy | Source Code

Created by Brian Gaudino. Data sourced from ClinicalTrials.gov, PubMed, and other public sources.

Parkinson's Digest is provided for informational and educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding medical decisions.

© 2026 Parkinson's Digest